4,404
Views
7
CrossRef citations to date
0
Altmetric
Reviews

Amanitin intoxication: effects of therapies on clinical outcomes – a review of 40 years of reported cases

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 1251-1265 | Received 04 Jun 2021, Accepted 30 Jun 2022, Published online: 21 Sep 2022

References

  • Liu J, Chen Y, Gao Y, et al. N-acetylcysteine as a treatment for amatoxin poisoning: a systematic review. Clin Toxicol. 2020;58(11):1015–1022.
  • Escudié L, Francoz C, Vinel JP, et al. Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol. 2007;46(3):466–473.
  • Schenk-Jaeger KM, Rauber-Lüthy C, Bodmer M, et al. Mushroom poisoning: a study on circumstances of exposure and patterns of toxicity. Eur J Intern Med. 2012;23(4):e85–91–e91.
  • Aveline J. The death of claudius. Hist - Zeitschrift Fur Alte Geschichte. 2004;53(4):453–475.
  • De Olano J, Wang JJ, Villeneuve E, et al. Current fatality rate of suspected cyclopeptide mushroom poisoning in the United States. Clin Toxicol. 2021;59(1):24–27.
  • Karlson-Stiber C, Persson H. Cytotoxic fungi - An overview. Toxicon. 2003;42(4):339–349.
  • Diaz JH. Amatoxin-Containing mushroom poisonings: species, toxidromes, treatments, and outcomes. Wilderness Environ Med. 2018;29(1):111–118.
  • Garcia J, Costa VM, Carvalho A, et al. Amanita phalloides poisoning: mechanisms of toxicity and treatment. Food Chem Toxicol. 2015;86:41–55.
  • Faybik P, Hetz H, Baker A, et al. Extracorporeal albumin dialysis in patients with amanita phalloides poisoning. Liver Int. 2003;23(Suppl. 3):28–33.
  • Alves A, Gouveia Ferreira M, Paulo J, et al. Mushroom poisoning with amanita phalloides - A report of four cases. Eur J Intern Med. 2001;12(1):64–66.
  • Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367–1384.
  • Shikdar S, Vashisht R, Bhattacharya P. International Normalized Ratio (INR) [Internet]. StatPearls Publishing. 2020. https://www.ncbi.nlm.nih.gov/books/NBK507707/
  • Santi L, Maggioli C, Mastroroberto M, et al. Acute liver failure caused by amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480.
  • Enjalbert F, Rapior S, Nouguier-Soulé J, et al. Treatment of amatoxin poisoning: 20-Year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715–757.
  • Klein AS, Hart J, Brems JJ, et al. Amanita poisoning: Treatment and the role of liver transplantation. Am J Med. 1989;86(2):187–193.
  • Vesconi S, Langer M, Iapichino G, et al. Therapy of cytotoxic mushroom intoxication. Crit Care Med. 1985;13(5):402–406.
  • Ye Y, Liu Z. Management of amanita phalloides poisoning: a literature review and update. J Crit Care. 2018;46(36):17–22.
  • Ng VL. Liver disease, coagulation testing, and hemostasis. Clin Lab Med. 2009;29(2):265–282.
  • DePond W. The relationship of the international normalized ratio (INR) to the prothrombin time (PT). Medlab. 2011;6:1–6.
  • Lindahl TL, Egberg N, Hillarp A, et al. INR calibration of owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost. 2004;91(6):1223–1231.
  • Harrison MF. The misunderstood coagulopathy of liver disease: a review for the acute setting. West J Emerg Med. 2018;19(5):863–871.
  • Persson HE, Sjöberg GK, Haines JA, et al. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36(3):205–213.
  • Giannini L, Vannacci A, Missanelli A, et al. Amatoxin poisoning: a 15-year retrospective analysis and follow-up evaluation of 105 patients. Clin Toxicol. 2007;45(5):539–542.
  • Trakulsrichai S, Sriapha C, Tongpoo A, et al. Clinical characteristics and outcome of toxicity from amanita mushroom poisoning. Int J Gen Med. 2017;10:395–400.
  • Langer M, Gridelli B, Piccolo G, et al. A liver transplant candidate (fulminant hepatic failure from amanita phalloides poisoning) as a multiorgan donor. Transplant Proc. 1997;29(8):3343–3344.
  • Lionte C, Sorodoc L, Simionescu V. Successful treatment of an adult with amanita phalloides-induced fulminant liver failure with molecular adsorbent recirculating system (MARS). Rom J Gastroenterol. 2005;14(3):267–271.
  • Shi Y, He J, Chen S, et al. MARS: Optimistic therapy method in fulminant hepatic failure secondary to cytotoxic mushroom poisoning - A case report. Liver. 2002;22(SUPPL. 2):78–80.
  • Erguven M, Yilmaz O, Deveci M, et al. Mushroom poisoning. Indian J Pediatr. 2007;74(9):847–852.
  • Olesen LL. Amatoxin intoxication. Scand J Urol Nephrol. 1990;24(3):231–234.
  • Olson KR, Pond SM, Seward J, et al. Amanita phalloides-type mushroom poisoning. West J Med. 1982;137(4):282–289.
  • Teutsch C, Brennan RW. Amanita mushroom poisoning with recovery from coma: a case report. Ann Neurol. 1978;3(2):177–179.
  • Dumont AM, Chennebault JM, Alquier P, et al. Management of amanita phalloides poisoning by bastien’s regimen. Lancet. 1981;1(8222):722.
  • Plotzker R, Jensen DM, Payne JA. Amanita virosa acute hepatic necrosis: Treatment with thioctic acid. Am J Med Sci. 1982;283(2):79–82.
  • Hazani E, Taitelman U, Shasha SM. Amanita verna poisoning in Israel - Report of a rare case of time and place. Arch Toxicol. 1983;53:186–189. p.
  • Hruby K, Csomos G, Fuhrmann M, et al. Chemotherapy of amanita phalloides poisoning with intravenous silibinin. Hum Toxicol. 1983;2(2):183–195.
  • Belliardo F, Massano G, Accomo S. Amatoxins do not cross the placental barrier. Lancet. 1983;1(8338):1381.
  • Kendrick B, Shimizu A. Mushroom poisoning: Analysis of two cases, and a possible new treatment. Plasmapheresis. Mycologia. 1984;76(3):448–453.
  • Woodle ES, Moody RR, Cox KL, et al. Orthotopic liver transplantation in a patient with amanita poisoning. JAMA. 1985;253(1):69–70.
  • Pond SM, Olson KR, Woo OF, et al. Amatoxin poisoning in Northern California, 1982-1983. West J Med. 1986;145(2):204–209.
  • Sanz P, Reig R, Piqueras J, et al. Fatal mushroom poisoning in barcelona, 1986-1988. Mycopathologia. 1989;108(3):207–209.
  • Piering WF, Bratanow N. Role of the clinical laboratory in guiding treatment of amanita virosa mushroom poisoning: Report of two cases. Clin Chem. 1990;36(3):571–574.
  • Pinson CW, Daya MR, Benner KG, et al. Liver transplantation for severe amanita phalloides mushroom poisoning. Am J Surg. 1990;159(5):493–499.
  • Lawrence RA, Pehlivanoglu E, Canpolat C. Treatment of amanita phalloides intoxication: a report of 3 cases and review of the literature. Marmara Med J. 1990;(3):42–45.
  • Cappell MS, Hassan T. Gastrointestinal and hepatic effects of amanita phalloides ingestion. J Clin Gastroenterol. 1992;15(3):225–228.
  • Galler GW, Weisenberg E, Brasitus TA. Mushroom poisoning: the role of orthotopic liver transplantation. J Clin Gastroenterol. 1992;15(3):229–232.
  • Christen Y, Minazio P, De Moerloose P. Monitoring of haemostatic parameters in five cases of amanita phalloides poisoning. Blood Coagul Fibrinolysis. 1993;4(4):627–630.
  • Pérez-Moreno J, Pérez-Moreno A, Ferrera-Cerrato R. Multiple fatal mycetism caused by amanita virosa in Mexico. Mycopathologia. 1994;125(1):3–5.
  • Nagy I, Pogatsa-Murray G, Zalanyi S, et al. Amanita poisoning during the second trimester of pregnancy. Clin Investig. 1994;72(10):794–798.
  • Yacyshyn B, Cheung CM, Malkin DG, et al. A potential prognostic indicator of fulminant hepatic failure: a valuable adjunct in preliver transplant assessment? Can J Gastroenterol. 1994;8(5):308–312.
  • Aji DY, Çalişkan S, Nayir A, et al. Haemoperfusion in amanita phalloides poisoning. J Trop Pediatr. 1995;41(6):371–374.
  • Gonzalez J, Lacomis D, Kramer DJ. Mushroom myopathy. Muscle Nerve. 1996;19(6):790–792.
  • Serné EH, Toorians AWFT, Gietema JA, et al. Amanita phalloides, a potentially lethal mushroom: Its clinical presentation and therapeutic options. Neth J Med. 1996;49(1):19–23.
  • Rosenthal P, Roberts JP, Ascher NL, et al. Auxiliary liver transplant in fulminant failure. Pediatrics. 1997;100(2):E10.
  • Korman MG, Nicholson FB, Korman MG. Death from amanita poisoning. Aust N Z J Med. 1997;27(4):448–449.
  • Zevin S, Dempsey D, Olson K. Amanita phalloides mushroom poisoning-Northern California. Clin Toxicol. January 1997;35(5):461–463. 1997
  • Scocco P, Rupolo G, Leo DD. Failed suicide by amanita phalloides (mycetismus) and subsequent liver transplant: Case report. Arch Suicide Res. 1998;4(2):201–206.
  • Chaiear K, Limpaiboon R, Meechai C, et al. Fatal mushroom poisoning caused by amanita virosa in Thailand. Southeast Asian J Trop Med Public Health. 1999;30(1):157–160. p.
  • Horn KD, Wax P, Schneider SM, et al. Biomarkers of liver regeneration allow early prediction of hepatic recovery after acute necrosis. Am J Clin Pathol. 1999;112(3):351–357.
  • Trim GM, Lepp H, Hall MJ, et al. Poisoning by amanita phalloides ('deathcap’) mushrooms in the Australian Capital Territory. Med J Aust. 1999;171(5):247–249.
  • Splendiani G, Zazzaro D, Di Pietrantonio P, et al. Continuous renal replacement therapy and charcoal plasmaperfusion in treatment of amanita mushroom poisoning. Artif Organs. 2000;24(4):305–308.
  • Lim JG, Kim JH, Lee CY, et al. Amanita virosa induced toxic hepatitis: report of three cases. Yonsei Med J. 2000;41(3):416–421.
  • Broussard CN, Aggarwal A, Lacey SR, et al. Mushroom poisoning-from diarrhea to liver transplantation. Am J Gastroenterol. 2001;96(11):3195–3198.
  • Boyer JC, Hernandez F, Estorc J, et al. Management of maternal amanita phalloïdes poisoning during the first trimester of pregnancy: a case report and review of the literature. Clin Chem. 2001;47(5):971–974.
  • Himmelmann A, Mang G, Schnorf-Huber S. Lethal ingestion of stored amanita phalloides mushrooms. Swiss Med Wkly. 2001;131(41-42):616–617.
  • Jander S, Bischoff J. Treatment of amanita phalloides poisoning: I. Retrospective evaluation of plasmapheresis in 21 patients. Ther Apher. 2000;4(4):303–307.
  • Hallik M, Tamme K, Väli T, et al. Successful liver transplantation after 21 days of hepatic coma. Asaio J. 2011;57(6):545–546.
  • Covic A, Goldsmith DJA, Gusbeth-Tatomir P, et al. Successful use of molecular absorbent regenerating system (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int. 2003;23(SUPPL. 3):21–27.
  • Wu BF, Wang MM. Molecular adsorbent recirculating system in dealing with maternal amanita poisoning during the second pregnancy trimester: a case report. Hepatobiliary Pancreat Dis Int. 2004;3(1):152–154.
  • Kucuk HF, Karasu Z, Kilic M, et al. Liver failure in transplanted liver due to amanita falloides (sic). Transplant Proc. 2005;37(5):2224–2226.
  • Hydzik P, Gawlikowski T, Ciszowski K, et al. Liver albumin dialysis (MARS)–treatment of choice in amanita phalloides poisoning? Przegl Lek. 2005;62(6):475–479.
  • Madhok M, Scalzo AJ, Blume CM, et al. Amanita bisporigera ingestion. Pediatr Emerg Care. 2006;22(3):177–180.
  • Araz C, Karaaslan P, Esen A, et al. Successful treatment of a child with fulminant liver failure and coma due to amanita phalloides poisoning using urgent liver transplantation. Transplant Proc. 2006;38(2):596–597.
  • Soysal D, Çevik Ç, Saklamaz A, et al. Coagulation disorders secondary to acute liver failure in amanita phalloides poisoning: a case report. Turkish J Gastroenterol. 2006;17(3):198–202.
  • Xiao GL, Zhang CH, Liu FY, et al. Clinical experience in treatment of amanita mushroom poisoning with glossy ganoderma decoction and routine Western medicines. Chin J Integ Med. 2007;13(2):145–147.
  • Krenová M, Pelclová D, Navrátil T. Survey of amanita phalloides poisoning: Clinical findings and follow-up evaluation. Hum Exp Toxicol. 2007;26(12):955–961.
  • Unverir P, Soner BC, Dedeoglu E, et al. Renal and hepatic injury with elevated cardiac enzymes in amanita phalloides poisoning: a case report. Hum Exp Toxicol. 2007;26(9):757–761.
  • Ennecker-Jans SAM, Van Daele PLA, Blonk MI, et al. Amatoxin poisoning due to soup from personally picked deathcap mushrooms (amanita phalloides. Ned Tijdschr Geneeskd. 2007;151(13):764–768.
  • Thaler T, Aceto L, Kupferschmidt H, et al. First intoxication with freshly picked amanita phalloides in winter time in Central Europe. J Gastrointest Liver Dis. 2008;17(1):111–117.
  • Yildiz BD, Abbasoglu O, Saglam A, et al. Urgent liver transplantation for amanita phalloides poisoning. Pediatr Transplant. 2008;12(1):105–108.
  • Wacker A, Riethmüller J, Zilker T, et al. Fetal risk through maternal amanita phalloides poisoning at the end of pregnancy. Am J Perinatol. 2009;26(3):211–214.
  • Garrouste C, Hémery M, Boudat AM, et al. Amanita phalloides poisoning-induced end-stage renal failure. Clin Nephrol. 2009;71(5):571–574.
  • Jiranantakan T, Olson KR, Magge HB. Acute pancreatitis in amanita phalloides poisoning. Clin Toxicol. 2009;47(7):702–765.
  • Matthews A, Kleiman R, Thomas J, et al. Abstracts of the 2009 North American congress of clinical toxicology annual meeting, september 21–26, 2009, san antonio, Texas, USA (abstract 208. Survival of amanita virosa poisoning treated with plasmapheresis). Clin Toxicol. 2009;47(7):702–765.
  • Aygul N, Duzenli MA, Ozdemir K, et al. A case report of an unusual complication of amanita phalloides poisoning: Development of cardiogenic shock and its successful treatment with intra-aortic balloon counterpulsation. Toxicon. 2010;55(2-3):630–632.
  • Põld K, Oder M, Paasma R. Abstracts of the 2010 international congress of the european association of poisons centres and clinical toxicologists, 11-14 may 2010, bordeaux, France (abstract 314. Poisoning by amanita phalloides). Clin Toxicol. 2010;48(3):240–318.
  • Mrzljak A, Knotek M, Gustin D, et al. End-stage kidney disease after mushroom poisoning and ABO-incompatible liver transplantation. Nephrology (Carlton). 2010;15(6):660–661.
  • Evrenoglou D, Michelidou S, Sakagianni K. 23rd ESICM annual congress – barcelona, Spain – 9–13 october 2010 (abstract 1299. Mushroom poisoning: Successful treatment with silibinin and N-acetylcysteine). Intensive Care Med. 2010;36(S2):326–433.
  • Sorodoc L, Lionte C, Sorodoc V, et al. Is MARS system enough for A.phalloides-induced liver failure treatment? Hum Exp Toxicol. 2010;29(10):823–832.
  • Lu F, Li G, Lu G, et al. Acute liver failure resulting from toadstool poison in three patients. ADRJ. 2010;12(4):273–275.
  • Cassidy N, Duggan E, Tracey JA. Mushroom poisoning in Ireland: the collaboration between the national poisons information Centre and expert mycologists. Clin Toxicol (Phila). 2011;49(3):171–176.
  • Freeman RJ, Elko CJ, Martin TG, et al. Abstracts (abstract 194. An amanita phalloides poisoning in Washington state confirmed by poison center field collection. Clin Toxicol. 2011;49(6):515–627. )
  • Garcia De La Fuente I, McLin VA, Rimensberger PC, et al. Amanita poisoning and liver transplantation: Do we have the right decision criteria? J Pediatr Gastroenterol Nutr. 2011;53(4):459–462.
  • Méndez-Navarro J, Ortiz-Olvera NX, Villegas-Ríos M, et al. Hepatotoxicity from ingestion of wild mushrooms of the genus amanita section phalloideae collected in Mexico city: two case reports. Ann Hepatol. 2011;10(4):568–574.
  • Cress CM, Malliah A, Herrine SK. Fulminant hepatic failure caused by amanita phalloides toxicity. Clin Gastroenterol Hepatol. 2011;9(2):A26.
  • French LK, Hendrickson RG, Horowitz BZ. Amanita phalloides poisoning. Clin Toxicol (Phila). 2011;49(2):128–129.
  • Bergis D, Friedrich-Rust M, Zeuzem S, et al. Treatment of amanita phalloides intoxication by fractionated plasma separation and adsorption (prometheus®). J Gastrointest Liver Dis. 2012;21(2):171–176.
  • Oghabian Z. Baniasad N, darvish moghadam S. Successful management of severe hepatotoxicity after fungal poisoning with amanita sp. of a patient: a case report. J Gastroenterol Hepatol. 2012;27(Suppl. 5):59–438.
  • Hays H, Casavant M, Jolliff H. Annual meeting of the North American congress of clinical toxicology (NACCT) october 1–6, 2012 las vegas, NV, USA (abstract 191. Not just for elementary school: a field trip and a new antidote solidify trainees’ knowledge of amatoxin poisoning). Clin Toxicol. 2012. 2012;50(7):574–720.
  • Chen WC, Kassi M, Saeed U, et al. A rare case of amatoxin poisoning in the state of Texas. Case Rep Gastroenterol. 2012;6(2):350–357.
  • Lawton LD, Bhraonain SN. Accidental poisoning by death cap mushrooms: Be careful what you eat. Wilderness Environ Med. 2013;24(2):168–170.
  • Roberts DM, Hall MJ, Falkland MM, et al. Amanita phalloides poisoning and treatment with silibinin in the Australian Capital Territory and New South Wales. Med J Aust. 2013;198(1):43–47.
  • Ward J, Kapadia K, Brush E, et al. Amatoxin poisoning: Case reports and review of current therapies. J Emerg Med. 2013;44(1):116–121.
  • Erden A, Esmeray K, Karagöz H, et al. Acute liver failure caused by mushroom poisoning: a case report and review of the literature. Int Med Case Rep J. 2013;6(1):85–90.
  • Grabhorn E, Nielsen D, Hillebrand G, et al. Successful outcome of severe amanita phalloides poisoning in children. Pediatr Transplant. 2013;17(6):550–555.
  • Vanooteghem S, Decock S, Arts J, et al. Four patients with amanita phalloides poisoning. Gut. 2013;62(Suppl 1):A187.1–A187.
  • Altintepe L, Yazici R, Yazici M, et al. Temporary left ventricular dysfunction in mushroom poisoning: Report of three cases. Ren Fail. 2014;36(8):1337–1339.
  • Baniasad N, Oghabian Z, Mehrpour O. Hepatotoxicity due to mushroom poisoning: a case report. Int J Med Toxicol Forensic Med. 2014;4(2):68–73.
  • Purcell MM, Marraffa JM. XXXIV international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 27–30 may 2014, brussels, Belgium (abstract 219. Aggressive treatment results in complete resolution of amanita bisporigera toxicity). Clin Toxicol. 2014;52(4):295–443.
  • Dirican A, Yilmaz M, Baskiran A, et al. Urgent liver transplantation for amanita phalloides caused acute liver failure. Eur Univ Inst. 2014;(2):2–5.
  • Chan YC, Tse ML, Lau FL. Hong Kong poison information Centre: Annual report 2013. Hong Kong J Emerg Med. 2014;21(4):249–259.
  • Sodavarapu S, Singh S, Hosea S. Fulminant hepatic failure after consumption of wild mushrooms. Am J Gastroenterol. 2014;109:S389.
  • Frass M, Zagorchev P, Yurukova V, et al. Two cases of fulminant hepatic failure from amanita phalloides poisoning treated additively by homeopathy. Ochsner J. 2014;14(2):252–258.
  • Zhang J, Zhang Y, Peng Z, et al. Experience of treatments of amanita phalloides–induced fulminant liver failure with molecular adsorbent recirculating system and therapeutic plasma exchange. Asaio J. 2014;60(4):407–412.
  • Gores KM, Hamieh TS, Schmidt GA. Survival following investigational treatment of amanita mushroom poisoning: Thistle or shamrock? Chest. 2014;146(4):e126–9.
  • Verma N, Bhalla A, Kumar S, et al. Wild mushroom poisoning in North India: Case series with review of literature. J Clin Exp Hepatol. 2014;4(4):361–365.
  • Ros JJW, Semplonius G, Mulder-Spijkerboer HN, et al. Intoxicatie met groene knolamaniet (amanita phalloides). Pharm Weekbl. 2015;150(22):117–120.
  • Yilmaz I, Ermis F, Akata I, et al. A case study: What doses of amanita phalloides and amatoxins are lethal to humans? Wilderness Environ Med. 2015;26(4):491–496.
  • Rahmani F, Bakhtavar HE, Ghavidel A. Acute hepatorenal failure in a patient following consumption of mushrooms: a case report. Iran Red Crescent Med J. 2015;17(3):1–4.
  • Garcia J, Costa VM, Costa AE, et al. Co-ingestion of amatoxins and isoxazoles-containing mushrooms and successful treatment: a case report. Toxicon. 2015;103:55–59.
  • Chibishev A, Perevska Z, Simonovska N, et al. Severe mushroom poisoning in one macedonian family. Int J Artif Organs. 2015;38(8):425–432.
  • Hendrik Pillukat M, Schomacher T, Baier P, et al. Early initiation of MARS® dialysis in amanita phalloides-induced acute liver injury prevents liver transplantation. Ann Hepatol. 2016;15(5):775–787.
  • Olsson EK, Petersson E. 36th international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 24-27 may, 2016, Madrid, Spain (abstract 312. Amatoxin poisoning during pregnancy: a case report and review of the literature). Clin Toxicol. 2016;54(4):344–519.
  • Arif T, Schiel H, Bartecka-Mino K. 36th international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 24-27 may, 2016, Madrid, Spain (abstract 300. Amanita phalloides ingestion in children in Austria, 1996 to 2014). Clin Toxicol. 2016;54(4):344–519.
  • Stankiewicz R, Lewandowski Z, Kotulski M, et al. Effectiveness of fractionated plasma separation and absorption as a treatment for amanita phalloides poisoning. Ann Transplant. 2016;21:428–432.
  • Vondran FWR, Schumacher C, Johanning K, et al. Application of the liver maximum function capacity test in acute liver failure: a helpful tool for Decision-Making in liver transplantation? Case Rep Transplant. 2016;2016:7074636–7074635.
  • Zhu S, Chen ZH, Zhou P, et al. 起因食用淡红鹅膏菌引起的中毒事件报告[a case report of intoxication caused by amanita pallidorosea]. Prev Med. 2016;28(7):719–720. 一 Chinese.
  • Austin E, Tirona R, Thompson M, et al. North American congress of clinical toxicology (NACCT) abstracts 2017 (abstract 35. Cyclosporine as a novel treatment for amatoxin-containing mushroom poisoning). Clin Toxicol. 2017;55(7):689–868.
  • Vendramin A, Jamsek M, Brvar M. 37th international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 16-19 may 2017, basel, Switzerland (abstract 295. Amanita phalloides poisoning in Slovenia, 1999–2015). Clin Toxicol. 2017;55(5):371–544.
  • Pantoflicek T, Fronek J. The 52nd congress of the european society for surgical research [abstract O112 AB0 – incompatible split liver transplantation in a married couple with fulminant hepatic failure due to mushroom poisoning (amanita phalloides) – a case report]. Eur Surg Res. 2017;58:1–69.
  • Surmaitis R, Pietrowski M, Kolecki P, et al. Abstracts from the 2017 American college of medical toxicology (ACMT) annual scientific meeting (abstract 57. Thistle while you work: a case of mushroom poisoning with liver recovery evident before silibinin administration). J Med Toxicol. 2017;13(1):3–46.
  • Vo KT, Montgomery ME, Mitchell ST, et al. Amanita phalloides mushroom poisonings — Northern California, december 2016. MMWR Morb Mortal Wkly Rep. 2017;66(21):549–553.
  • Ma KW, Chok KSH, Chan CK, et al. Liver transplantation: a life-saving procedure following amatoxin mushroom poisoning. Hong Kong Med J. 2017;23(1):93–96.
  • Hongo T, Zheng M, Malamood M, et al. A case of amanita phalloides poisoning that avoided liver transplantation. Med Forum. 2017;18(1):12–13.
  • Dutta A, Kumar Dutta P, Kar S. Mushroom poisoning induced acute liver failure with deranged coagulation profile. jemds. 2017;6(66):4783–4786.
  • Li Y, Mu M, Yuan L, et al. Challenges in the early diagnosis of patients with acute liver failure induced by amatoxin poisoning. Medicine. 2018;97(27):e11288.
  • Barman B, Warjri S, Lynrah KG, et al. Amanita nephrotoxic syndrome: Presumptive first case report on the indian subcontinent. Indian J Nephrol. 2018;28(2):170–172.
  • Foutris A, Kalostou A, Basanou E. 38th international congress of the european association of poisons centres and clinical toxicologists (EAPCCT) 22-25 may 2018, bucharest, Romania (abstract 278. Amanita phalloides poisoning: effectiveness of timely administration of antidotes). Clin Toxicol. 2018;56(6):453–608.
  • Kieslichova E, Frankova S, Protus M, et al. Acute liver failure due to amanita phalloides poisoning: Therapeutic approach and outcome. Transplant Proc. 2018;50(1):192–197.
  • Schmutz M, Carron PN, Yersin B, et al. Mushroom poisoning: a retrospective study concerning 11-years of admissions in a swiss emergency department. Intern Emerg Med. 2018;13(1):59–67.
  • Pakala T, Siu M, Bunim A, et al. Amanita phalloides induced hepatitis: Watch out for renal failure? Am J Gastroenterol. 2018;113(Supplement):S1259.
  • Lu Z, Chen YB, Huang B, et al. Mixed amanita phalloides poisoning with rhabdomyolysis: analysis of 4 cases. J South Med Univ. 2018;38(5):635–638.
  • Sun J, Li HJ, Zhang HS, et al. Investigating and analyzing three cohorts of mushroom poisoning caused by amanita exitialis in Yunnan, China. Hum Exp Toxicol. 2018;37(7):665–678.
  • Baskiran A, Dirican A, Ozgor D, et al. Significance and outcome of living-donor liver transplantation in acute mushroom intoxication. Niger J Clin Pract. 2018;21(7):888–893.
  • Olaru C, Burlea LS, Rosu TS. Gastritis masking late symptoms of mushroom poisoning in a teenager. a case report. Rom J Oral Rehabil. 2018;10(1):160–165.
  • Pillay Mauree A, de Maayer T, Botes A, et al. Amanita phalloides poisoning: One harvest, three outcomes. S Afr j Surg. 2019;57(1):61–64.
  • Beaumier M, Rioult JP, Georges M, et al. Mushroom poisoning presenting with acute kidney injury and elevated transaminases. Kidney Int Rep. 2019;4(6):877–881.
  • Karakoç E, Demirtaş K, Ekemen S, et al. Mushroom that breaks hearts: a case report. Turkish J Intensive Care. 2019;18(1):43–46.
  • Mărginean CO, Meliţ LE, Mărginean MO. Mushroom intoxication, a fatal condition in romanian children: Two case reports. Medicine. 2019;98(41):e17574.
  • Wang Q, Sun M, Lv H, et al. Amanita fuliginea poisoning with thrombocytopenia: a case series. Toxicon. 2020;174(October 2019):43–47.
  • Ye Y, Liu Z, Zhao M. CLIF-OF >9 predicts poor outcome in patients with amanita phalloides poisoning. Am J Emerg Med. 2021;39:96–101.
  • Ganzert M, Felgenhauer N, Zilker T. Indication of liver transplantation following amatoxin intoxication. J Hepatol. 2005;42(2):202–209.
  • Letschert K, Faulstich H, Keller D, et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes. Toxicol Sci. 2006;91(1):140–149.
  • Khunnala A, Narongchai S, Butkrachang S, et al. Anti-Oxidative stress activities of silibinin on Į-Amanitin in vitro. Thai J Toxicol. 2009;24(2):106–112.
  • Magdalan J, Piotrowska A, Gomułkiewicz A, et al. Benzylpenicyllin and acetylcysteine protection from α-amanitin-induced apoptosis in human hepatocyte cultures. Exp Toxicol Pathol. 2011;63(4):311–315.
  • Fraschini F, Demartini G, Esposti D. Pharmacology of silymarin. Clin Drug Investig. 2002;22(1):51–65.
  • Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, et al. Hepatoprotective effect of silymarin. World J Hepatol. 2014;6(3):144–149.
  • Berczyński P, Kładna A, Kruk I, et al. Radical-scavenging activity of penicillin G, ampicillin, oxacillin, and dicloxacillin. J Biol Chem Lumin. 2017;32(3):434–442.
  • Hellerbrand C, Schattenberg JM, Peterburs P, et al. The potential of silymarin for the treatment of hepatic disorders. Clin Phytosci. 2017;2(1):7.
  • Mengs U, Torsten Pohl R, Mitchell T. Legalon® SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. Curr Pharm Biotechnol. 2012;13(10):1964–1970.
  • Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001;61(14):2035–2063.
  • Chughlay MF, Kramer N, Werfalli M, et al. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review protocol. Syst Rev. 2015;4(1):1–6.
  • Sklar GE, Subramaniam M. Acetylcysteine treatment for Non-Acetaminophen-Induced acute liver failure. Ann Pharmacother. 2004;38(3):498–501.
  • Rank N, Michel C, Haertel C, et al. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study. Crit Care Med. 2000;28(12):3799–3807.
  • Poucheret P, Fons F, Doré JC, et al. Amatoxin poisoning treatment decision-making: Pharmaco-therapeutic clinical strategy assessment using multidimensional multivariate statistic analysis. Toxicon. 2010;55(7):1338–1345.
  • Connors NJ, Gosselin S, Hoffman RS. Comment on “N-acetylcysteine as a treatment for amatoxin poisoning. Clin Toxicol. 2021;59(6):534–535.
  • Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–96.
  • Eren SH, Demirel Y, Ugurlu S, et al. Mushroom poisoning: Retrospective analysis of 294 cases. Clinics. 2010;65(5):491–496.
  • Dutta A, Bora K. Elevated transaminases as predictor of mortality in mushroom poisoning patients. J Evol Res Med Biochem. 2016;2(2):1–3.
  • Mydlik M, Derzsiova K. Liver and kidney damage in acute poisonings. Bantao J. 2006;4(1):30–33.
  • Easterbrook PJ, Gopalan R, Berlin JA, et al. Publication bias in clinical research. Lancet. 1991;337(8746):867–872.
  • Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol (Phila). 2007;45(8):943–945.